Page last updated: 2024-08-22

angiotensin ii and Stroke

angiotensin ii has been researched along with Stroke in 81 studies

Research

Studies (81)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (2.47)	18.2507
2000's	53 (65.43)	29.6817
2010's	23 (28.40)	24.3611
2020's	3 (3.70)	2.80

Authors

Authors	Studies
Chen, GH; Chen, JT; Ge, YJ; He, S; Kong, XY; Li, XY; Yang, S; Zhang, P	1
Girouard, H; Vallerand, D; Youwakim, J	1
Balyan, R; Munshi, A; Vasudeva, K	1
Alatawi, Y; Alghamdi, BS; Alshehri, FS; Balabagno, AO; Chen, Y; Durmanova, V; Evangelista, LS; Hromadka, T; Javor, J; Ji, Q; Jiao, J; Kralova, M; Kurdi, M; Labban, S; Li, X; Li, Y; Lv, Q; Minarik, G; Ocenasova, A; Pagsibigan, JS; Parnicka, Z; Reznakova, V; Shawkatova, I; Shen, ZJ; Tian, X; Tu, S; Tuazon, JA; Vaseckova, B; Wang, XY; Wang, Z; Xue, Y; Zeng, LX; Zhang, S; Zhang, ZH; Zuo, C	1
Akazawa, H; Isobe, M; Koriyama, H; Mochizuki, H; Morishita, R; Nakagami, H; Shimamura, M; Suzuki, JI; Wakayama, K; Watanabe, R	1
Dai, Y; Dong, Y; Li, Z; Xiong, Y; Xu, C; Yan, Z	1
Andrews, KL; Chin-Dusting, JPF; Dragoljevic, D; Gaspari, T; Jefferis, AM; Jennings, GL; Khan, SI; Lee, MKS; Moore, XL; Murphy, AJ; Shihata, WA; Vinh, A	1
Dong, H; Fang, J; Li, Y; Liu, L; Ming, S	1
Lu, J; Xu, F; Zhang, J	1
Deng, YT; Li, CG; Li, HM; Li, MC; Liu, SQ; Su, YY; Wei, JP; Xie, HF; Yan, ZX; Zheng, WX	1
Endo, M; Fukuda, N; Ikeda, K; Kobayashi, N; Matsumoto, K; Soma, M; Ueno, T	1
He, L; He, Q; Li, C; Li, M; Li, X; Li, Y; Peng, Y; Shen, Q; Tang, Y; Wang, Y	1
Horiuchi, M; Kawajiri, M; Matsumoto, S; Mogi, M; Tsukuda, K; Yamada, T	1
He, DH; Lin, JX; Lin, LM; Ning, RB; Wang, HJ; Xu, CS; Zhang, LM	1
Chen, SZ; Chen, YF; Lazartigues, E; Li, GZ; Olson, JE; Wang, JJ; Xia, HJ; Zheng, JL; Zhu, YL	1
Bihl, J; Buck, J; Chen, S; Chen, Y; Lazartigues, E; Li, G; Olson, JE; Xia, H; Zheng, J; Zhu, Y	1
Back, C; Edvinsson, L; Iversen, HK; Jensen, LT; Larsen, VA; Skovgaard, K; Thiesen, KL	1
Cribbs, DH; Gillen, DL; Kilday, K; Passos, GF; Vasilevko, V	1
Abdul Aziz, Z; Bots, ML; Hwong, WY; Kappelle, LJ; Selvarajah, S; Sidek, NN; Spiering, W; Vaartjes, I	1
Dong, YF; Fukuda, M; Kataoka, K; Kim-Mitsuyama, S; Matsuba, S; Nakamura, T; Ogawa, H; Tamamaki, N; Tokutomi, Y; Yamamoto, E	1
Côté, R; Keezer, MR; Wolfson, C; Yu, AY; Zhu, B	1
Auffarth, GU; Bettendorf, M; Grundt, C; Inta, I; Lemmer, B; Schwaninger, M; Veltkamp, R; Weber, D; Winteroll, S	1
Drummond, GR; Jackman, KA; Miller, AA; Sobey, CG	1
Chu, Y; Heistad, DD; Miller, JD; Rosenberg, GA; Wakisaka, Y	1
Beattie, WS; Dattani, ND; Hare, GM; Leong-Poi, H; Liu, E; Mazer, CD; Mitsakakis, N; Noronha, M; Ragoonanan, TE; Tait, G; Tsui, AK; Wilson, DF; Yu, J	1
Cheng, JW; Lu, GC; Ma, XJ; Shen, FM; Su, DF; Zhu, KM	1
Chrissobolis, S; Drummond, GR; Kemp-Harper, BK; Miller, AA; Sobey, CG	1
Aoyama, T; Minatoguchi, S	1
Joseph, JP; Katovich, MJ; Mecca, AP; O'Connor, TE; Raizada, MK; Regenhardt, RW; Sumners, C	1
Granger, DN; Rodrigues, SF	1
Saavedra, JM	1
Mitsuyama, S	1
Altura, BM; Altura, BT; Gebrewold, A; Zheng, T	1
Gaede, P; Jensen, GV; Larsen, N; Parving, HH; Pedersen, O; Vedel, P	1
Hankey, GJ	1
Gaede, PH; Jensen, GV; Jepsen, PV; Larsen, JN; Parving, HH; Pedersen, OB	1
Diener, HC; Lüders, S; Schrader, J	1
Müller-Nordhorn, J; Willich, SN	1
Gerzanich, V; Ivanova, S; Simard, JM	1
Bramlage, P; Dikow, R; Kirch, W; Lehnert, H; Pittrow, D; Ritz, E; Wittchen, HU	1
Gorelick, PB; Iadecola, C	1
Antonicelli, R; Germanò, G	1
Isaka, N; Ito, M; Kaibuchi, K; Kongo, M; Kureishi, Y; Moriki, N; Nakakuki, T; Nakano, T; Okamoto, R; Seko, T	1
Iigaya, K; Kumagai, H; Onami, T; Saruta, T; Takimoto, C	1
Mancia, G	1
Fujioka, S; Hamada, J; Hasegawa, Y; Hashiguchi, A; Kai, Y; Miura, M; Morioka, M; Todaka, T; Ushio, Y; Yano, S	1
Volpe, M	1
Ferrario, CM	1
Chrysant, SG	2
Ikeda, K; Xu, JW; Yamori, Y	1
Ioroi, T; Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Tanaka, T; Wanibuchi, H; Yamamoto, E; Zhan, Y	1
Savoia, C; Schiffrin, EL; Tabet, F; Touyz, RM; Yao, G	1
Hattori, Y; Jesmin, S; Kitabatake, A; Miyauchi, T; Sakuma, I; Togashi, H; Yoshioka, M	1
Battegay, E; Zeller, A	1
Hirata, K; Inoue, N; Ishida, T; Kojima, Y; Quertermous, T; Shimokawa, Y; Yokoyama, M	1
Ishida, H; Ito, H; Takemori, K	1
Ikami, T; Ikeda, K; Kayano, Y; Kobayakawa, A; Li, PG; Mitani, T; Xu, JW; Yamori, Y	1
Kidwell, CS; Ovbiagele, B; Rajajee, V; Razinia, T; Saver, JL; Selco, SL; Starkman, S	1
Steckelings, UM; Thöne-Reineke, C; Unger, T	1
Tanahashi, N	1
Devereux, RB; Krauser, DG	1
Achard, JM; Chapot, R; Faure, S; Javellaud, J; Oudart, N; Tallet, D	1
Ageno, W; Dentali, F; Romualdi, E	1
Feng, HY; Li, CM; Lu, XL; Qiu, SL; Su, QX; Zeng, Y; Zhang, C; Zhang, HL	1
Achard, JM; Boutitie, F; Fournier, A; Gueyffier, F; Mazouz, H; Messerli, FH; Oprisiu, R; Wang, J	1
Victor, RG	1
Capone, C; Girouard, H; Iadecola, C; Lessard, A; Milner, TA	1
Liu, AJ; Liu, JG; Shen, FM; Su, DF; Yi-Ming, W; Zhang, W	1
Camm, J; Savelieva, I	1
Bader, M; Hata, R; Hossmann, KA; Maeda, K; Walther, T	1
Achard, JM; Andrejak, M; Fernandez, LA; Fournier, A; Hottelart, C; Mazouz, H; Pruna, A; Rosa, A	1
Achard, JM; Esper, NE; Fournier, A; Makdassi, R; Mazouz, H; Oprisiu, R; Pruna, A; Westeel, PF	1
Laverty, R; Ledingham, JM	1
August, P; Leventhal, B; Suthanthiran, M	1
Hayashi, M; Nakaya, H; Saruta, T; Sasamura, H	1
Anderson, JW; Bains, JS; Ferguson, AV; Follwell, MJ; Latchford, KJ	1
Bader, M; Harms, C; Hörtnagl, H; Maul, B; Mies, G; Olah, L; Schultheiss, HP; Walther, T	1
Brosnan, MJ; Dominiczak, AF; Graham, D; Hamilton, CA; Jardine, E; Lygate, CA	1
Achard, JM; Andrejak, M; Fernandez, L; Fournier, A; Godefroy, O; Mazouz, H	1
Imaki, T; Naruse, M; Sato, A; Takagi, S; Takano, K; Tanabe, A; Tsuchiya, K	1

Reviews

26 review(s) available for angiotensin ii and Stroke

Article	Year
ACE-Triggered Hypertension Incites Stroke: Genetic, Molecular, and Therapeutic Aspects. Neuromolecular medicine, 2020, Volume: 22, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Gene Expression Regulation, Enzymologic; Humans; Hypertension; Macrophages; Mice; MicroRNAs; Mutation, Missense; Myocytes, Smooth Muscle; Neuroglia; Peptidyl-Dipeptidase A; Polymorphism, Single Nucleotide; Renin-Angiotensin System; Stroke	2020
A systematic review of angiotensin receptor blockers in preventing stroke. Stroke, 2009, Volume: 40, Issue:12 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiovascular Diseases; Humans; Hypertension; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Risk Factors; Stroke; Treatment Outcome	2009
Oxidative stress and endothelial dysfunction in cerebrovascular disease. Frontiers in bioscience (Landmark edition), 2011, 01-01, Volume: 16, Issue:5 Topics: Alzheimer Disease; Amidohydrolases; Angiotensin II; Animals; Brain Ischemia; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelium, Vascular; Humans; Hypertension; Mitochondria; Nitric Oxide; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Reperfusion Injury; Stroke; Subarachnoid Hemorrhage; Superoxide Dismutase	2011
[The effect of ARB on prevention of atherosclerosis]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Humans; Inflammation; Myocardial Infarction; Oxidative Stress; Randomized Controlled Trials as Topic; Risk Factors; Stroke	2011
Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clinical science (London, England : 1979), 2012, Volume: 123, Issue:10 Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Brain; Brain Diseases; Brain Injuries; Brain Ischemia; Humans; Inflammation; Mood Disorders; Neurodegenerative Diseases; Neuroprotective Agents; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Stress, Physiological; Stroke	2012
[Role of the renin-angiotensin system in the brain and cardiorenal system]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2012, Volume: 140, Issue:3 Topics: Angiotensin II; Animals; Brain Diseases; Cognition Disorders; Endothelium, Vascular; Heart Diseases; Humans; Kidney Diseases; Nitric Oxide Synthase Type III; Oxidative Stress; Renin-Angiotensin System; Stroke; Vascular Diseases	2012
Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE? Stroke, 2003, Volume: 34, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Life Style; Practice Guidelines as Topic; Ramipril; Risk; Risk Factors; Stroke; Telmisartan	2003
[Cerebrovascular sequelae of hypertension]. Herz, 2003, Volume: 28, Issue:8 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dementia, Vascular; Diuretics; Humans; Hypertension; Risk Factors; Stroke; Treatment Outcome	2003
Angiotensin II antagonists in the treatment of hypertension-effective and efficient? Herz, 2003, Volume: 28, Issue:8 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Humans; Hypertension; Kidney Failure, Chronic; Stroke; Treatment Outcome	2003
[What is new about stroke prevention?]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2003, Volume: 4, Issue:12 Topics: Aged; Angiotensin II; Clinical Trials as Topic; Humans; Stroke	2003
[Organ protection by angiotensin II receptor blockers]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cognition Disorders; Heart Failure; Humans; Hypertension; Kidney Diseases; Losartan; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Proteins; Proteinuria; Randomized Controlled Trials as Topic; Stroke; Tetrazoles	2004
Prevention and treatment of stroke in patients with hypertension. Clinical therapeutics, 2004, Volume: 26, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Anticoagulants; Antihypertensive Agents; Costs and Cost Analysis; Humans; Hypertension; Losartan; Quality of Life; Randomized Controlled Trials as Topic; Risk Factors; Stroke	2004
Treatment of systolic hypertension: spotlight on recent studies with angiotensin II antagonists. Journal of human hypertension, 2005, Volume: 19, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Clinical Trials as Topic; Humans; Hypertension; Losartan; Patient Compliance; Practice Guidelines as Topic; Stroke; Systole	2005
The role of angiotensin antagonism in stroke prevention in patients with hypertension: focus on losartan. Current medical research and opinion, 2004, Volume: 20, Issue:11 Topics: Angiotensin II; Antihypertensive Agents; Clinical Trials as Topic; Humans; Hypertension; Losartan; Stroke	2004
Stroke prevention with losartan in the context of other antihypertensive drugs. Drugs of today (Barcelona, Spain : 1998), 2004, Volume: 40, Issue:9 Topics: Angiotensin II; Antihypertensive Agents; Clinical Trials as Topic; Humans; Losartan; Stroke	2004
[Angiotensin II receptor blockers--evidence along the cardiovascular continuum]. Praxis, 2005, Apr-13, Volume: 94, Issue:15 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dogs; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Placebos; Rabbits; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Stroke; Tetrazoles; Time Factors	2005
Angiotensin receptor blockers and cerebral protection in stroke. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2006, Volume: 24, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Humans; Neuroprotective Agents; Receptor, Angiotensin, Type 2; Stroke	2006
[Stroke and renin-angiotensin system]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Humans; NADPH Oxidases; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Stroke	2006
Ventricular hypertrophy and hypertension: prognostic elements and implications for management. Herz, 2006, Volume: 31, Issue:4 Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan	2006
The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications. Journal of clinical hypertension (Greenwich, Conn.), 2007, Volume: 9, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Humans; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stroke; Vasoconstriction	2007
Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II. Journal of hypertension, 2007, Volume: 25, Issue:8 Topics: Angiotensin II; Antihypertensive Agents; Humans; Placebos; Randomized Controlled Trials as Topic; Risk Factors; Stroke	2007
Pathophysiology of target-organ disease: does angiotensin II remain the key? Journal of clinical hypertension (Greenwich, Conn.), 2007, Volume: 9, Issue:11 Suppl 4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Disease Progression; Humans; Hypertension; Losartan; Myocardial Infarction; Renin; Renin-Angiotensin System; Stroke; Tetrazoles; Treatment Outcome; Valine; Valsartan	2007
Update on atrial fibrillation: part I. Clinical cardiology, 2008, Volume: 31, Issue:2 Topics: Angiotensin II; Anti-Arrhythmia Agents; Atrial Appendage; Atrial Fibrillation; Catheter Ablation; Fibrinolytic Agents; Humans; Risk Assessment; Stroke	2008
Prevention of stroke and cancer: could angiotensin II type 1 receptor antagonists do better than angiotensin II converting enzyme inhibitors? American journal of hypertension, 1999, Volume: 12, Issue:10 Pt 1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Humans; Neoplasms; Stroke	1999
Captopril prevention project--what shall we do about captopril and the risk of stroke? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Brain Ischemia; Captopril; Humans; Hypertension; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke	2000
Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence. Current hypertension reports, 2000, Volume: 2, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Black People; Coronary Disease; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Linear Models; Prevalence; Stroke; Transforming Growth Factor beta; White People	2000

Trials

4 trial(s) available for angiotensin ii and Stroke

Article	Year
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England journal of medicine, 2003, Jan-30, Volume: 348, Issue:5 Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins	2003
[The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]. Ugeskrift for laeger, 2003, Jun-23, Volume: 165, Issue:26 Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins	2003
Angiotensin 2 type 2 receptor activity and ischemic stroke severity. Neurology, 2005, Sep-27, Volume: 65, Issue:6 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Brain; Brain Ischemia; Calcium Channel Blockers; Cerebral Arteries; Cerebrovascular Circulation; Female; Humans; Male; Prospective Studies; Receptor, Angiotensin, Type 2; Secondary Prevention; Sodium Chloride Symporter Inhibitors; Stroke; Treatment Outcome	2005
Captopril prevention project--what shall we do about captopril and the risk of stroke? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Brain Ischemia; Captopril; Humans; Hypertension; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke	2000

Other Studies

52 other study(ies) available for angiotensin ii and Stroke

Article	Year
Changed serum levels of CD62E Sleep medicine, 2022, Volume: 91 Topics: Angiotensin II; Biomarkers; E-Selectin; Glycopeptides; Humans; Hypertension; Sleep Initiation and Maintenance Disorders; Stroke	2022
Neurovascular Coupling in Hypertension Is Impaired by IL-17A through Oxidative Stress. International journal of molecular sciences, 2023, Feb-16, Volume: 24, Issue:4 Topics: Alzheimer Disease; Angiotensin II; Humans; Hypertension; Interleukin-17; NADPH Oxidases; Neurovascular Coupling; Oxidative Stress; Stroke; Superoxides	2023
Acta medica Philippina, 2017, Volume: 51, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II; Animals; Antithrombins; Atrial Fibrillation; Body Mass Index; Catheter Ablation; Cohort Studies; Dabigatran; Dogs; Embolism; Factor Xa Inhibitors; Female; Genotype; Hemorrhage; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Middle Aged; Norepinephrine; Obesity; Polymorphism, Single Nucleotide; Retrospective Studies; Rivaroxaban; Stroke; Sympathectomy	2017
Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress. Stroke, 2017, Volume: 48, Issue:5 Topics: Angiotensin II; Animals; Antibodies; Brain Ischemia; Disease Models, Animal; Immunotherapy, Active; Infarction, Middle Cerebral Artery; Male; Oxidative Stress; Rats; Rats, Wistar; Renin-Angiotensin System; Stroke; Vaccines, Subunit	2017
Acetylshikonin attenuates angiotensin II-induced proliferation and motility of human brain smooth muscle cells by inhibiting Wnt/β-catenin signaling. Human cell, 2018, Volume: 31, Issue:3 Topics: Active Transport, Cell Nucleus; Angiotensin II; Anthraquinones; beta Catenin; Brain; Cell Cycle; Cell Movement; Cell Proliferation; Cells, Cultured; Cerebrovascular Disorders; Depression, Chemical; Drugs, Chinese Herbal; Glycogen Synthase Kinase 3 beta; Humans; Hyperplasia; Myocytes, Smooth Muscle; Phosphorylation; Phytotherapy; Stroke; Vascular Remodeling; Wnt Signaling Pathway	2018
Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:1 Topics: Adaptive Immunity; Angiotensin II; Animals; Aspirin; Biomarkers; Blood Pressure; Blood Vessels; Cardiomegaly; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Disease Susceptibility; Dose-Response Relationship, Drug; Epoprostenol; Hypertension; Kidney; Mice; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction; RNA, Messenger; Stroke; Systole; T-Lymphocytes; Thromboxanes	2019
Icariin ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting Nox2-containing NADPH oxidase activation. Human cell, 2019, Volume: 32, Issue:1 Topics: Angiotensin II; Animals; Basilar Artery; Brain; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Flavonoids; Humans; Hyperplasia; Hypertension; Muscle, Smooth, Vascular; NADPH Oxidase 2; NADPH Oxidases; Phytotherapy; Rats, Sprague-Dawley; Reactive Oxygen Species; Stroke; Vascular Remodeling	2019
Inhibition of angiotensin II-induced cerebrovascular smooth muscle cell proliferation by LRRC8A downregulation through suppressing PI3K/AKT activation. Human cell, 2019, Volume: 32, Issue:3 Topics: Angiotensin II; Animals; Cell Cycle; Cell Proliferation; Cells, Cultured; Down-Regulation; Gene Expression; Humans; Male; Membrane Proteins; Mice, Inbred C57BL; Molecular Targeted Therapy; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Stroke; Vascular Remodeling	2019
Renin-angiotensin system activation and imbalance of matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 in cold-induced stroke. Life sciences, 2019, Aug-15, Volume: 231 Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Cell Cycle Proteins; Cold Temperature; Humans; Kidney; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Renin-Angiotensin System; Stroke; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2	2019
Role of complement 3a in the growth of mesangial cells from stroke-prone spontaneously hypertensive rats. Clinical and experimental hypertension (New York, N.Y. : 1993), 2014, Volume: 36, Issue:1 Topics: Actins; Angiotensin II; Animals; Arginine; Benzhydryl Compounds; Cell Proliferation; Complement C3a; Gene Expression; Hypertension; Kidney Cortex; Male; Mesangial Cells; Myocytes, Smooth Muscle; Osteopontin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Complement; RNA, Messenger; Stroke	2014
Critical role of matrix metalloproteinase-9 in acute cold exposure-induced stroke in renovascular hypertensive rats. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2013, Volume: 22, Issue:8 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Brain; Disease Models, Animal; Doxycycline; Hypertension, Renovascular; Hypothermia, Induced; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Stroke; Time Factors	2013
Serum levels of renin-angiotensin system components in acute stroke patients. Geriatrics & gerontology international, 2014, Volume: 14, Issue:4 Topics: Acute Disease; Aged; Angiotensin II; Angiotensin-Converting Enzyme 2; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Male; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Retrospective Studies; Severity of Illness Index; Stroke	2014
Long-term prehypertension treatment with losartan effectively prevents brain damage and stroke in stroke-prone spontaneously hypertensive rats. International journal of molecular medicine, 2014, Volume: 33, Issue:2 Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Apoptosis; Blood Pressure; Brain; Hypertension; Losartan; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Prehypertension; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Stroke; Superoxide Dismutase; Time Factors	2014
Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence. CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:5 Topics: Age Factors; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Brain; Brain Edema; Brain Ischemia; Cell Death; Female; Glucose; Hypoxia, Brain; Infarction, Middle Cerebral Artery; Male; Membrane Glycoproteins; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Neurons; Peptide Fragments; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Stroke; Tissue Culture Techniques	2014
Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction. Neuroscience, 2014, Jul-25, Volume: 273 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Brain; Brain Edema; Brain Ischemia; CA1 Region, Hippocampal; Cell Death; Cerebral Cortex; Glucose; Hypoxia; Membrane Glycoproteins; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Neurons; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction; Stroke; Tissue Culture Techniques	2014
RAAS and stress markers in acute ischemic stroke: preliminary findings. Acta neurologica Scandinavica, 2015, Volume: 131, Issue:2 Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Animals; Biomarkers; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System; Stroke	2015
Experimental hypertension increases spontaneous intracerebral hemorrhages in a mouse model of cerebral amyloidosis. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2016, Volume: 36, Issue:2 Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II; Animals; Blood Pressure; Brain; Cerebral Amyloid Angiopathy; Female; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Risk Factors; Stroke	2016
Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II? PloS one, 2016, Volume: 11, Issue:11 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Brain Ischemia; Calcium Channel Blockers; Cross-Sectional Studies; Diuretics; Female; Humans; Hypertension; Malaysia; Male; Middle Aged; Multivariate Analysis; Registries; Severity of Illness Index; Stroke	2016
Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke, 2008, Volume: 39, Issue:11 Topics: Acetophenones; Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Astrocytes; Blood Pressure; Cerebral Cortex; Enzyme Activation; Enzyme Inhibitors; Humans; Hydralazine; Hypertension; Inflammation; Male; NADPH Oxidases; Neurons; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Sodium Chloride; Stroke; Tetrazoles; Valine; Valsartan	2008
Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes. Cerebrovascular diseases (Basel, Switzerland), 2009, Volume: 27, Issue:4 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Quebec; Retrospective Studies; Severity of Illness Index; Stroke	2009
Correlation of soluble gp130 serum concentrations with arterial blood pressure. Journal of hypertension, 2009, Volume: 27, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Carotid Arteries; Case-Control Studies; Cell Culture Techniques; Cells, Cultured; Cytokine Receptor gp130; Endothelin-1; Female; Gene Expression; Heart Rate; Humans; Immunohistochemistry; Male; Middle Aged; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Species Specificity; Stroke; Telemetry; Telmisartan; Time Factors; Tunica Intima; Tunica Media; Vasoconstrictor Agents; Young Adult	2009
Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke. Brain research, 2009, Aug-25, Volume: 1286 Topics: Angiotensin II; Animals; Cerebral Cortex; Cerebrovascular Circulation; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Mice, Knockout; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Stroke; Superoxides	2009
Spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2010, Volume: 30, Issue:1 Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Fluorescent Antibody Technique; Gelatin; Hypertension; Immunohistochemistry; Intracranial Hemorrhages; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Norepinephrine; Oxidative Stress; Reverse Transcriptase Polymerase Chain Reaction; Stroke; Vasoconstrictor Agents	2010
Metoprolol reduces cerebral tissue oxygen tension after acute hemodilution in rats. Anesthesiology, 2009, Volume: 111, Issue:5 Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Brain; Cardiac Output; Catecholamines; Cerebrovascular Circulation; Erythropoietin; Hemodilution; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Metoprolol; Oxygen; Rats; Rats, Sprague-Dawley; Stroke	2009
Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Experimental physiology, 2011, Volume: 96, Issue:10 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Endothelin-1; Enzyme Activation; Infarction, Middle Cerebral Artery; Male; Nitric Oxide Synthase Type II; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Stroke	2011
Cerebral microvascular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2012, Volume: 32, Issue:2 Topics: Angiotensin II; Animals; Blood Platelets; Blood Pressure; Brain; Cell Adhesion; Cytokines; Desoxycorticosterone; Hypertension; Leukocytes; Male; Mice; Mice, Inbred C57BL; Microvessels; Mineralocorticoids; Mitochondria; Reactive Oxygen Species; Stroke; Superoxides	2012
Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke. Brain research bulletin, 2002, Volume: 58, Issue:3 Topics: Angiotensin II; Animals; Brain Injuries; Capillary Permeability; Cell Communication; Ceramides; Cerebral Veins; Dinoprost; Dose-Response Relationship, Drug; Encephalitis; Endothelium, Vascular; Leukocytes; Male; Rats; Rats, Wistar; Serotonin; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingomyelins; Stroke; Vasoconstriction; Venules	2002
Early pathophysiological changes in cerebral vessels predisposing to stroke. Clinical hemorheology and microcirculation, 2003, Volume: 29, Issue:3-4 Topics: Amlodipine; Angiotensin II; Animals; Arterioles; Benzylamines; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; CREB-Binding Protein; Disease Susceptibility; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation; Hyperplasia; Hypertension; Models, Animal; Muscle, Smooth, Vascular; Nicotine; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nuclear Proteins; Oxidative Stress; Proliferating Cell Nuclear Antigen; Rats; Stroke; Sulfonamides; Trans-Activators	2003
[Microalbuminuria is an early marker for increased morbidity and mortality]. Fortschritte der Medizin. Originalien, 2003, Feb-27, Volume: 121 Suppl 1 Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Losartan; Male; Meta-Analysis as Topic; Prevalence; Proteinuria; Renin-Angiotensin System; Risk Factors; Stroke	2003
Hypertension, angiotensin, and stroke: beyond blood pressure. Stroke, 2004, Volume: 35, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Cerebrovascular Circulation; Humans; Hypertension; Renin-Angiotensin System; Risk Factors; Signal Transduction; Stroke	2004
RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:4 Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Cells, Cultured; Cyclic AMP; Cyclic GMP; Hypertension; Muscle, Smooth, Vascular; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Signal Transduction; Stroke; Tetrazoles; Valine; Valsartan	2004
Contribution of angiotensin-converting enzyme and angiotensin II to ischemic stroke: their role in the formation of stable and unstable carotid atherosclerotic plaques. Surgical neurology, 2004, Volume: 62, Issue:4 Topics: Actins; Aged; Angiotensin II; Arteriosclerosis; Brain Ischemia; Carotid Stenosis; Female; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Platelet Endothelial Cell Adhesion Molecule-1; Stroke	2004
Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:9 Topics: Angiotensin II; Anilides; Animals; Aorta, Thoracic; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Hypertension; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; PPAR gamma; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Signal Transduction; Stroke; Superoxides; Tyrosine; Vasoconstrictor Agents	2004
Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats. Stroke, 2005, Volume: 36, Issue:5 Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood-Brain Barrier; Calcium Channel Blockers; Cell Proliferation; Cerebral Arteries; Cerebral Cortex; Disease Models, Animal; Hippocampus; Hypertensive Encephalopathy; Male; Neurons; Oxidative Stress; Rats; Rats, Inbred SHR; Sodium Chloride; Stroke; Superoxides; Tetrazoles	2005
Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. Journal of hypertension, 2005, Volume: 23, Issue:5 Topics: Angiotensin II; Animals; Hypertension; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myosin Light Chains; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; rhoA GTP-Binding Protein; Stroke; Vasodilation	2005
Effects of endothelin receptor antagonist on expression of AT1 and AT2 receptors in the heart of SHR-SP. Journal of cardiovascular pharmacology, 2004, Volume: 44 Suppl 1 Topics: Angiotensin II; Animals; Coronary Vessels; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Hypertension; Indans; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Stroke	2004
Increased expression of endothelial lipase in rat models of hypertension. Cardiovascular research, 2005, Jun-01, Volume: 66, Issue:3 Topics: Amino Acid Sequence; Angiotensin II; Animals; Aorta; Base Sequence; Blotting, Northern; Cells, Cultured; Humans; Hypertension; Kidney; Lipase; Lung; Male; Mice; Molecular Sequence Data; Muscle, Smooth, Vascular; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; RNA, Messenger; Sequence Alignment; Stroke; Tetradecanoylphorbol Acetate	2005
Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats. Life sciences, 2005, Sep-16, Volume: 77, Issue:18 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Cerebral Cortex; Histocytochemistry; Hypertension; Intercellular Adhesion Molecule-1; Kidney; Male; Myocardium; Nephrosclerosis; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Stroke	2005
Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:4 Topics: Angiotensin II; Animals; Antioxidants; Caffeic Acids; Cell Division; DNA-Binding Proteins; Drug Interactions; Enzyme Inhibitors; HSP90 Heat-Shock Proteins; Hypertension; Janus Kinase 2; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; STAT1 Transcription Factor; Stroke; Superoxides; Trans-Activators; Tyrosine; Tyrphostins; Vasoconstrictor Agents	2005
Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2006, Volume: 57, Issue:3 Topics: Analysis of Variance; Angiotensin II; Animals; Brain; Brain Ischemia; Cerebral Angiography; Disease Models, Animal; Dose-Response Relationship, Drug; Intracranial Embolism; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Regional Blood Flow; Stroke; Vasoconstriction	2006
The metabolic syndrome and the risk of thrombosis. Haematologica, 2007, Volume: 92, Issue:3 Topics: Adiponectin; Adipose Tissue; Angiotensin II; Anthropometry; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Cytokines; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Metabolic Syndrome; Obesity; Plasminogen; Prevalence; Prospective Studies; Risk Factors; Stroke; Thrombophilia; Thrombosis; Tissue Plasminogen Activator	2007
[Relationship between angiotensin converting enzyme gene and ischemic stroke]. Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2007, Volume: 19, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Asphyxia; Brain Ischemia; Disease Models, Animal; Female; Genetic Predisposition to Disease; Genotype; Humans; Hypoxia; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Risk Factors; Stroke	2007
The neurovascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:1 Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Blood Flow Velocity; Blood Pressure; Cerebrovascular Circulation; Disease Models, Animal; Disease Susceptibility; Estradiol; Estrogen Replacement Therapy; Female; Hypertension; Infusion Pumps, Implantable; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Neocortex; Ovariectomy; Reflex; Sex Factors; Stroke; Time Factors; Vasodilator Agents; Vibrissae	2008
Pressor and non-pressor effects of sodium loading on stroke in stroke-prone spontaneously hypertensive rats. Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:1 Topics: Angiotensin II; Animals; Baroreflex; Blood Pressure; Brain; Disease Models, Animal; Female; Heart Rate; Hypertension; Interleukin-1beta; Interleukin-6; Intracranial Aneurysm; Rats; Rats, Inbred SHR; Regression Analysis; Sodium Chloride, Dietary; Stroke; Time Factors; Tumor Necrosis Factor-alpha	2008
Larger anastomoses in angiotensinogen-knockout mice attenuate early metabolic disturbances after middle cerebral artery occlusion. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1999, Volume: 19, Issue:10 Topics: Acute Disease; Adenosine Triphosphate; Angiotensin II; Animals; Anterior Cerebral Artery; Arterial Occlusive Diseases; Brain Ischemia; Cerebrovascular Circulation; Collateral Circulation; Female; Infarction, Middle Cerebral Artery; Latex; Mice; Mice, Knockout; Middle Cerebral Artery; Renin-Angiotensin System; Stroke	1999
Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril. Clinical and experimental pharmacology & physiology, 2000, Volume: 27, Issue:8 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Basilar Artery; Blood Pressure; Brain; Enalapril; Enzyme Inhibitors; Hypertension; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Stroke; Tetrazoles; Valine; Valsartan; Ventricular Function, Left	2000
Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis. Journal of the American Society of Nephrology : JASN, 2001, Volume: 12, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Gene Expression; Genetic Predisposition to Disease; Hydralazine; Hypertension; Indans; Kidney; Male; Nephrosclerosis; Proteinuria; Rats; Rats, Inbred SHR; Renin; Stroke; Tetrazoles; Time Factors; Vasodilator Agents	2001
Slowly inactivating potassium conductance (I(D)): a potential target for stroke therapy. Stroke, 2001, Volume: 32, Issue:11 Topics: 4-Aminopyridine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Death; Cells, Cultured; Electric Conductivity; Excitatory Postsynaptic Potentials; Humans; Hypothalamus; Kinetics; Male; N-Methylaspartate; Neurons; Neuroprotective Agents; Paraventricular Hypothalamic Nucleus; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Stroke	2001
Ischemic injury in experimental stroke depends on angiotensin II. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:2 Topics: Angiotensin II; Animals; Brain; Brain Ischemia; Female; Mice; Mice, Knockout; Mice, Transgenic; Neurons; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Stroke	2002
Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats. Journal of hypertension, 2002, Volume: 20, Issue:2 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Biological Availability; Biphenyl Compounds; Blood Pressure; Blood Vessels; Disease Models, Animal; Drug Therapy, Combination; Female; Hypertension; Immunohistochemistry; Irbesartan; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Nitric Oxide; Phosphoproteins; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Stroke; Superoxides; Tetrazoles	2002
Re: Slowly activating potassium conductance (I(D)): a potential target for stroke therapy. Stroke, 2002, Volume: 33, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Excitatory Amino Acid Agonists; Paraventricular Hypothalamic Nucleus; Potassium Channels; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke	2002
Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:1 Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Corticosterone; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypertension; Imidazoles; Male; Natriuretic Peptide, Brain; Prodrugs; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Spironolactone; Stroke; Tetrazoles; Time Factors	2002